ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) was the target of a large increase in short interest in August. As of August 14th, there was short interest totaling 26,467 shares, an increase of 61.6% from the July 30th total of 16,382 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 51,884 shares, the short-interest ratio is currently 0.5 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, ALPS Group Inc Ordinary Share has an average rating of “Sell”.
Read Our Latest Research Report on ALPS
ALPS Group Inc Ordinary Share Stock Down 0.1%
ALPS Group Inc Ordinary Share Company Profile
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
See Also
- Five stocks we like better than ALPS Group Inc Ordinary Share
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
